Zelner, Jonathan L <br/><br/>
Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  Apr 2014 
 - 853-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-4970 
<br/><br/><label>Standard No.: </label>10.1164/rccm.201310-1896OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antitubercular Agents--therapeutic use<br/>BCG Vaccine<br/>Child<br/>Child, Preschool<br/>Contact Tracing<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infant<br/>Isoniazid--therapeutic use<br/>Male<br/>Middle Aged<br/>Models, Statistical<br/>Models, Theoretical<br/>Multivariate Analysis<br/>Odds Ratio<br/>Peru<br/>Prospective Studies<br/>Treatment Outcome<br/>Tuberculosis, Pulmonary--diagnosis<br/>Young Adult